Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Tuberculosis

Free Subscription Articles published in Lancet Retrieve available abstracts of 40 articles: HTML format Text format

Single Articles

November 2018
1. GRANICH R
   Is the global tuberculosis control strategy too big to fail?
   Lancet. 2018 Nov 1. pii: S0140-6736(18)32751.
   PubMed     Text format    
   
   
   October 2018
2. COUSINS S
   UN High-Level meeting to end tuberculosis disappointing.
   Lancet. 2018 Oct 3. pii: S0140-6736(18)32458.
   PubMed     Text format    
   
   
   September 2018
3. MARAIS B, Zumla A
   Advancing global tuberculosis control after the UNGA-HLM.
   Lancet. 2018 Sep 24. pii: S0140-6736(18)32361.
   PubMed     Text format    
   
   
   
4. AHMAD N, Ahuja SD, Akkerman OW, Alffenaar JC, et al
   Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.
   Lancet. 2018;392:821-834.
   PubMed     Text format     Abstract available
   
   
   
5. FARMER PE
   Better and safer treatment for multidrug-resistant tuberculosis.
   Lancet. 2018;392:798-800.
   PubMed     Text format    
   
   
   
6. REUTER A, Furin J
   Reducing harm in the treatment of multidrug-resistant tuberculosis.
   Lancet. 2018;392:797-798.
   PubMed     Text format    
   
   
   August 2018
7. GARBARINO MC, Cani V, Mazzarello P
   A century ago: Carlo Forlanini and the first successful treatment of tuberculosis.
   Lancet. 2018;392:475.
   PubMed     Text format    
   
   
   July 2018
8. GUPTA-WRIGHT A, Corbett EL, van Oosterhout JJ, Wilson D, et al
   Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial.
   Lancet. 2018 Jul 19. pii: S0140-6736(18)31267.
   PubMed     Text format     Abstract available
   
   
   
9. NATHAVITHARANA RR, Pai M
   New strategies for inpatients with HIV and tuberculosis.
   Lancet. 2018 Jul 19. pii: S0140-6736(18)31442.
   PubMed     Text format    
   
   
   May 2018
10. COUSINS S
    Managing MDR tuberculosis in Nepal.
    Lancet. 2018;391:1760-1761.
    PubMed     Text format    
    
    
    April 2018
11. COSTELLO A
    The Global Fund links with Lombard Odier bank.
    Lancet. 2018;391:1674-1675.
    PubMed     Text format    
    
    
    March 2018
12. PARK KB, Khan U, Seung K
    Open letter to The Global Fund about its decision to end DPRK grants.
    Lancet. 2018;391:1257.
    PubMed     Text format    
    
    
    
13. SHARMA D
    Commitments to an end to tuberculosis renewed in India.
    Lancet. 2018;391:1138.
    PubMed     Text format    
    
    
    
14. GOOSBY E, Jamison D, Swaminathan S, Reid M, et al
    The Lancet Commission on tuberculosis: building a tuberculosis-free world.
    Lancet. 2018;391:1132-1133.
    PubMed     Text format    
    
    
    
15. WINGFIELD T, Tovar MA, Datta S, Saunders MJ, et al
    Addressing social determinants to end tuberculosis.
    Lancet. 2018;391:1129-1132.
    PubMed     Text format    
    
    
    
16. DAVIES R
    Leo Martinez: striving to end childhood tuberculosis.
    Lancet. 2018 Mar 21. pii: S0140-6736(18)30680.
    PubMed     Text format    
    
    
    
17. THE LANCET
    The Global Fund under Peter Sands.
    Lancet. 2018;391:912.
    PubMed     Text format    
    
    
    January 2018
18. THE LANCET
    Tuberculosis: criteria for global leadership?
    Lancet. 2018;391:2.
    PubMed     Text format    
    
    
    September 2017
19. POKROVSKY V
    Tuberculosis and HIV/AIDS: the alien and the predator.
    Lancet. 2017;390:1618-1619.
    PubMed     Text format    
    
    
    
20. COX H, Reuter A, Furin J, Seddon J, et al
    Prevention of hearing loss in patients with multidrug-resistant tuberculosis.
    Lancet. 2017;390:934.
    PubMed     Text format    
    
    
    June 2017
21. VENKATESH P
    Tuberculosis in India: health policy alone is not enough.
    Lancet. 2017;389:2471.
    PubMed     Text format    
    
    
    
22. PAI M, Jha P
    Tuberculosis in India: health policy alone is not enough - Authors' reply.
    Lancet. 2017;389:2471-2472.
    PubMed     Text format    
    
    
    March 2017
23. SHARMA DC
    New plan to end tuberculosis in south and southeast Asia.
    Lancet. 2017;389:1183.
    PubMed     Text format    
    
    
    
24. ADAM BU, Cosford P, Anderson SR, Abubakar I, et al
    Sustaining tuberculosis decline in the UK.
    Lancet. 2017;389:1176-1177.
    PubMed     Text format    
    
    
    
25. PAI M, Correa N, Mistry N, Jha P, et al
    Reducing global tuberculosis deaths-time for India to step up.
    Lancet. 2017;389:1174-1176.
    PubMed     Text format    
    
    
    February 2017
26. SHARMA DC
    India plans to expand access to new tuberculosis drug.
    Lancet. 2017;389:685.
    PubMed     Text format    
    
    
    
27. COUSINS S
    Myanmar grapples with its high tuberculosis burden.
    Lancet. 2017;389:491-492.
    PubMed     Text format    
    
    
    January 2017
28. CLINTON C, Sridhar D
    Who pays for cooperation in global health? A comparative analysis of WHO, the World Bank, the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria, and Gavi, the Vaccine Alliance.
    Lancet. 2017 Jan 27. pii: S0140-6736(16)32402.
    PubMed     Text format     Abstract available
    
    
    November 2016
29. CARRUTH L, Roess AA, Mekonnen YT, Melaku SK, et al
    Zoonotic tuberculosis in Africa: challenges and ways forward.
    Lancet. 2016;388:2460-2461.
    PubMed     Text format    
    
    
    
30. BERRY C, Achar J, du Cros P
    WHO recommendations for multidrug-resistant tuberculosis.
    Lancet. 2016;388:2234.
    PubMed     Text format    
    
    
    
31. SOTGIU G, Tiberi S, D'Ambrosio L, Centis R, et al
    WHO recommendations for multidrug-resistant tuberculosis - Authors' reply.
    Lancet. 2016;388:2234-2235.
    PubMed     Text format    
    
    
    
32. ZAK D, Scriba TJ, Hatherill M, Penn-Nicholson A, et al
    Predicting tuberculosis risk - Authors' reply.
    Lancet. 2016;388:2233-2234.
    PubMed     Text format    
    
    
    
33. KIK SV, Cobelens F, Moore D
    Predicting tuberculosis risk.
    Lancet. 2016;388:2233.
    PubMed     Text format    
    
    
    October 2016
34. NADDA JP, Singh PK
    New evidence of the tuberculosis burden in Asia demands national action.
    Lancet. 2016 Oct 14. pii: S0140-6736(16)31853.
    PubMed     Text format    
    
    
    
35. ALDRIDGE RW, Zenner D, White PJ, Williamson EJ, et al
    Tuberculosis in migrants moving from high-incidence to low-incidence countries: a population-based cohort study of 519 955 migrants screened before entry to England, Wales, and Northern Ireland.
    Lancet. 2016 Oct 10. pii: S0140-6736(16)31008.
    PubMed     Text format     Abstract available
    
    
    
36. REINL J
    UN declaration on antimicrobial resistance lacks targets.
    Lancet. 2016;388:1365.
    PubMed     Text format    
    
    
    
37. CHEN S, Zhang H, Qu Y, Wu Y, et al
    Occupational challenges of physicians involved in tuberculosis control in China: a qualitative study.
    Lancet. 2016;388 Suppl 1:S88.
    PubMed     Text format     Abstract available
    
    
    
38. GAO L, Bai L, Liu J, Lu W, et al
    Identification of populations at high risk of tuberculosis infection in rural China: a population-based, multicentre, prospective study.
    Lancet. 2016;388 Suppl 1:S16.
    PubMed     Text format     Abstract available
    
    
    July 2016
39. FEDER HM JR, Rigos L, Teti K
    Pott's disease in a Connecticut toddler.
    Lancet. 2016;388:504.
    PubMed     Text format    
    
    
    
40. RUBENSTEIN LS, Amon JJ, McLemore M, Eba P, et al
    HIV, prisoners, and human rights.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30663.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: